Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo
1 other identifier
interventional
461
1 country
1
Brief Summary
The purpose of this study is to demonstrate the validity and utility of a tele-dermatology system in the midterm periodic screening of non-widespread skin lesions of recent onset or for which a specialized early classification is deemed to change the prognosis - including precancerous skin lesions as well as melanoma and non-melanoma skin cancers - compared to control visits at fixed follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2016
CompletedFirst Posted
Study publicly available on registry
September 16, 2016
CompletedStudy Start
First participant enrolled
October 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2019
CompletedMay 17, 2019
May 1, 2019
2.6 years
September 8, 2016
May 16, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cumulative incidence of at least one non-widespread skin lesion identified and clinically confirmed as suspected / highly suspected
Two years
Secondary Outcomes (4)
Agreement between the tele-dermatology system and the direct dermatological visit as assessed by Cohen's kappa (within the experimental arm).
Within the two years study period
Cumulative incidence of at least one non-widespread skin lesion identified as suspected / highly suspected among subjects who did not use the tele-dermatology system (within the experimental arm).
Within the two years study period
Proportion of subjects who have at least one anticipated follow-up visit (within the comparator arm).
Within the two years study period
Proportion of subjects with at least one missed scheduled visit at follow-up(within the comparator arm).
Within the two years study period
Study Arms (2)
Screening
ACTIVE COMPARATORThis arm includes all subjects randomized to regular dermatological follow-up visits on annual basis.
Tele-dermatology
EXPERIMENTALThis arm includes all subjects randomized to the use of a tele-dermatology system for the evaluation of newly onset non-widespread skin lesions.
Interventions
The screening visit consists in a general dermatological examination of the subject, with special focus on the onset of the following skin diseases during the follow-up period: 1. bacterial skin infections - pyoderma - or viral (erysipelas, impetigo, herpes zoster, molluscum contagiosum, viral warts); 2. fungal skin infections (tinea corporis, cruris, pedis); 3. pigmented tumors (melanoma); 4. non-melanocytic tumors (actinic keratoses, basal cell or squamous cell carcinoma).
The system consists in a simple web-based/smartphone application through which subjects can send pictures of recently onset non-widespread skin lesions with special focus on the following diseases: 1. bacterial skin infections - pyoderma - or viral (erysipelas, impetigo, herpes zoster, molluscum contagiosum, viral warts); 2. fungal skin infections (tinea corporis, cruris, pedis); 3. pigmented tumors (melanoma); 4. non-melanocytic tumors (actinic keratoses, basal cell or squamous cell carcinoma). A dermatology will judge online pictures based on a standard scale. Each subject who will use the system will be also seen by routine clinical visit to confirm the online diagnosis. Subjects who will not send any picture will be seen for a dermatological examination at the end of each year.
Eligibility Criteria
You may qualify if:
- Subjects currently working at the Local Health Authority of the province of Bergamo
You may not qualify if:
- Subjects who are not able to use the tele-dermatology system or who have no access to the website or the specific app.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Local Health Authority (ATS)
Bergamo, 24121, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luigi Naldi, MD
Centro Studi Gised
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2016
First Posted
September 16, 2016
Study Start
October 1, 2016
Primary Completion
May 1, 2019
Study Completion
May 1, 2019
Last Updated
May 17, 2019
Record last verified: 2019-05